Log in
ASX:PME

Pro Medicus Limited (PME.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$26.98
MA: A$26.98▼
A$26.98
52-Week Range N/A
Volume285,954 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.41%
BetaN/A
Pro Medicus Limited provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions in Australia, Europe, and North America. It offers medical software for practice management; integration products; Promedicus.net secure email; healthcare software that provides radiologist and clinicians with advanced visualization capability for viewing 2-D, 3-D, and 4-D medical images; and PACS/Digital imaging software. The company offers its products under the Visage RIS, Visage RIS/PACS, and Visage 7 names. It also provides Visage Ease Pro, a mobile applications, which allow users access to medical imaging results that are stored on a Visage 7 server; training, installation, and professional services; and after sale support and service products. The company offers its products and services to hospitals, diagnostic imaging groups, and other health related entities. Pro Medicus Limited was founded in 1983 and is headquartered in Richmond, Australia.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.69 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolASX:PME
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.promed.com.au
Phone61 3 9429 8800
EmployeesN/A

Debt

Debt-to-Equity Ratio3.78
Current Ratio4.84
Quick Ratio4.75

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$56.82 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow71.76
Book ValueA$0.58 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PME News and Ratings via Email

Sign-up to receive the latest news and ratings for PME and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Pro Medicus Limited (PME.AX) (ASX:PME) Frequently Asked Questions

What stocks does MarketBeat like better than Pro Medicus Limited (PME.AX)?

Wall Street analysts have given Pro Medicus Limited (PME.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pro Medicus Limited (PME.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How often does Pro Medicus Limited (PME.AX) pay dividends? What is the dividend yield for Pro Medicus Limited (PME.AX)?

Pro Medicus Limited (PME.AX) declared a Final dividend on Friday, August 21st. Stockholders of record on Friday, October 2nd will be paid a dividend of 0.06 per share on Friday, October 2nd. This represents a dividend yield of 0.23%. The ex-dividend date is Thursday, September 10th. This is an increase from Pro Medicus Limited (PME.AX)'s previous Final dividend of A$0.05.
View Pro Medicus Limited (PME.AX)'s dividend history.

Who are some of Pro Medicus Limited (PME.AX)'s key competitors?

Some companies that are related to Pro Medicus Limited (PME.AX) include 1st Group Limited (1ST.AX) (1ST), Alcidion Group Limited (ALC.AX) (ALC), Cann American (CNNA), CannaOne Technologies (CNONF), CB2 Insights (CBIIF), CloudMD Software & Services (DOCRF), CloudMD Software & Services Inc. (DOC.V) (DOC), Cogstate Limited (CGS.AX) (CGS), CompuMed (CMPD), Corum Group Limited (COO.AX) (COO), EGF Theramed Health (EVAHF), Emyria Limited (EMD.AX) (EMD), eWellness Healthcare (EWLL), Global Health Limited (GLH.AX) (GLH) and ICS Global Limited (ICS.AX) (ICS).
View all competitors.

What other stocks do shareholders of Pro Medicus Limited (PME.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus Limited (PME.AX) investors own include ImmuPharma plc (IMM.L) (IMM), Blackmores Limited (BKL.AX) (BKL), Bank of America (BAC), The Boeing (BA), Accent Group Limited (AX1.AX) (AX1), Axos Financial (AX), ARB Co. Limited (ARB.AX) (ARB), Appen Limited (APX.AX) (APX), Arista Networks (ANET) and Altium Limited (ALU.AX) (ALU).

Who are Pro Medicus Limited (PME.AX)'s key executives?

Pro Medicus Limited (PME.AX)'s management team includes the following people:
  • Dr. Sam Aaron Hupert, Co-Founder, CEO, MD & Exec. Director
  • Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc., Co-Founder, Technology Director & Exec. Director
  • Dr. Malte Westerhoff, GM of Europe & Global CTO
  • Mr. Brad Levin, GM of North America & Global Head of Marketing
  • Mr. Sean Lambright, Global Head of Sales - Visage Imaging Inc
  • Mr. Clayton James Hatch CPA, B.Comm, CPA, CFO & Company Sec.

What is Pro Medicus Limited (PME.AX)'s stock symbol?

Pro Medicus Limited (PME.AX) trades on the ASX under the ticker symbol "PME."

How big of a company is Pro Medicus Limited (PME.AX)?

Pro Medicus Limited (PME.AX) has a market capitalization of $0.00 and generates $56.82 million in revenue each year.

What is Pro Medicus Limited (PME.AX)'s official website?

The official website for Pro Medicus Limited (PME.AX) is www.promed.com.au.

How can I contact Pro Medicus Limited (PME.AX)?

The company can be reached via phone at 61 3 9429 8800.

This page was last updated on 12/4/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.